Clinical Trials Directory

Trials / Completed

CompletedNCT01993485

The Effect of Transaortic Valve Replacement on the Endothelial Integrity and Function

Status
Completed
Phase
Study type
Observational
Enrollment
61 (actual)
Sponsor
Heinrich-Heine University, Duesseldorf · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Degenerative aortic valve stenosis (AVS) is the leading cause of aortic valve morbidity with a prevalence of 2-7% at ages above 65 years, with ever-increasing incidence especially in the 8th decades. AVS is independently associated with atheroclerosis risk factors and clinically apparent CV disease indicating that the degeneration of the aortic valve may represent an atheroclerosis-like process involving both, the aortic valve as well as the vascular system, respectivel. It is still unknown whether the endothelial function is affected as an manifestation of the atherosclerotic process, changes in the driving mechanical forces as WSS downstream of the valve, or other factors beyond physical pressure effects. The investigators hypothesized that altered haemodynamics may at least partly be responsible for observed endothelial dysfunction in patients with AVS. Therefore, the aim of this study is to investigate whether the resolution of AVS by transaortic valve implacement (TAVI) affects WSS, improves endothelial dysfunction and decreases levels of circulating EMPs as markers of endothelial integrity.

Conditions

Timeline

Start date
2013-06-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2013-11-25
Last updated
2014-06-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01993485. Inclusion in this directory is not an endorsement.